Healthcare - Biotechnology - NASDAQ - US
$ 104.54
-4.19 %
$ 9.99 B
Market Cap
70.16
P/E
Price Target
Average
70.77%
Revenue Forecast
Estimate
38.30%
EBIT
Estimate
--85.72%
Net Income
Estimate
49.41%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Sarepta Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for SRPT of $179 , with forecasts ranging from a low of $141 to a high of $205 .
SRPT Lowest Price Target
Wall Street Target
141 USD
34.88%
SRPT Average Price Target
Wall Street Target
179 USD
70.77%
SRPT Highest Price Target
Wall Street Target
205 USD
96.10%
REVENUE FORECAST
Revenue Forecast Chart SRPT
EBIT FORECAST
EBIT Forecast Chart SRPT
NET INCOME FORECAST
Net Income Chart SRPT